These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33891606)

  • 21. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
    Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
    Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different Neointimal Pattern in Early vs. Late In-Stent Restenosis and Clinical Outcomes After Drug-Coated Balloon Angioplasty　- An Optical Coherence Tomography Study.
    Lee JH; Jung HW; Kim JS; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
    Circ J; 2018 Oct; 82(11):2745-2752. PubMed ID: 30197402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological validation of frequency domain optical coherence tomography for the evaluation of neointimal formation after a novel polymer-free sirolimus-eluting stent implantation.
    Fu Q; Hu H; Chen W; Tan Z; Li L; Wang D; Chen B
    Int J Clin Exp Pathol; 2015; 8(9):11068-75. PubMed ID: 26617825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography.
    Vergallo R; Yonetsu T; Uemura S; Park SJ; Lee S; Kato K; Jia H; Abtahian F; Tian J; Hu S; Lee H; McNulty I; Prasad A; Yu B; Zhang S; Porto I; Biasucci LM; Crea F; Jang IK
    Am J Cardiol; 2013 Nov; 112(9):1315-21. PubMed ID: 23891431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance.
    Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Ibuki M; Hasegawa K; Ishibuchi K; Tamaru H; Yasuda S; Ishii R; Nakabayashi S; Kusumoto H; Higashino Y
    Heart Vessels; 2020 Jan; 35(1):38-45. PubMed ID: 31250131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis.
    Kim JS; Afari ME; Ha J; Tellez A; Milewski K; Conditt G; Cheng Y; Hua Yi G; Kaluza GL; Granada JF
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):292-8. PubMed ID: 24022066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neointimal tissue component assessed by tissue characterization with 40 MHz intravascular ultrasound imaging: comparison of drug-eluting stents and bare-metal stents.
    Tsujita K; Takaoka N; Kaikita K; Hokimoto S; Horio E; Sato K; Mizobe M; Nakayama N; Kojima S; Tayama S; Sugiyama S; Nakamura S; Ogawa H
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1068-74. PubMed ID: 23460385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, multicenter, randomized OCT study of early neointimal condition at first and second months after BuMA Supreme stent versus XIENCE stent implantation in high-bleeding-risk coronary artery disease patients: study protocol for a randomized controlled trial.
    Li B; Jin QH; Chen YD; Wang CQ; Shi B; Su X; Fu GS; Wu YQ; Zhou XC; Yuan ZY
    Trials; 2019 Jun; 20(1):335. PubMed ID: 31174600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
    Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells.
    Nicol P; Hoppman P; Euller K; Xhepa E; Lenz T; Rai H; Jinnouchi H; Bulin A; Castellanos MI; Lahmann AL; Koppara T; Kastrati A; Joner M
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):25-35. PubMed ID: 32761285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Importance of the LDL-C/Apolipoprotein B Ratio for Neointimal Formation after Everolimus-Eluting Stent Implantations.
    Akutsu N; Hori K; Mizobuchi S; Ogaku A; Koyama Y; Fujito H; Arai R; Ebuchi Y; Migita S; Morikawa T; Tamaki T; Kojima K; Murata N; Nishida T; Kitano D; Fukamachi D; Okumura Y
    J Atheroscler Thromb; 2022 Apr; 29(4):536-550. PubMed ID: 33746158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.
    Taniwaki M; Windecker S; Zaugg S; Stefanini GG; Baumgartner S; Zanchin T; Wenaweser P; Meier B; Jüni P; Räber L
    Eur Heart J; 2015 Aug; 36(32):2167-76. PubMed ID: 26040806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.
    Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study.
    Shiratori Y; Brugaletta S; Alvarez-Contreras L; Azpeitia Y; Ospino N; Gaido S; Delahanty A; Santos A; Martin-Yuste V; Masotti M; Serruys PW; Windecker S; Sabaté M
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E428-36. PubMed ID: 23441068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
    Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
    Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.